Saturday, January 18, 2020 5:04:27 PM
Momenta would have to increase another $30 to simply meet the average of the Nasdaq Index and increase $39 to match the IBB Biotech Average since it's IPO.
Since Craig took the helm in September of 2006 Momenta has climbed 105% which is good unless you compare it to the Nasdaq AVERAGE which is up 296% or the IBB which is up 359%.
P,S, They sell Index funds for investors who can't beat the averages.
There's nothing else to say.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM